Skip to main content
Clinical Trials/ISRCTN21989763
ISRCTN21989763Completed未知

Fish scale based ologen™ Biocornea for the emergency management of corneal perforations

Aeon Astron Europe B.V.0 sites7 target enrollmentStarted: July 25, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
7

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •1. Age =18 years
  • •2. Perforated corneal ulceration/laceration
  • •3. Leaking corneal defects with indication for corneal transplantation due to:
  • •3.1 Perforating corneal ulceration, or
  • •3.2 Perforating corneal trauma with loss of corneal tissue making primary wound closure by corneal suturing impossible
  • •4. Only one eye is affected by corneal ulceration / perforation / laceration. The non-affected eye has the potency of a minimum visual acuity of 0.63 (20/32).
  • •5. No human donor cornea nor 0-cornea” is available
  • •6. Subject must be able and willing to cooperate with the CIP
  • •7. Subject must be able and willing to complete postoperative follow-up requirements
  • •8. Subject must be able to understand and read the German language. In case reading is difficult (eye trauma) qualified staff will read out the ICF.
  • •9. Subject or witness has signed the ICF

Exclusion Criteria

  • •1. Known hypersensitivity to fish collagen
  • •2. Pregnant or breast-feeding women.
  • •3. Subject is participating in any other clinical trial or research project with an investigational medicinal product or a medical device or has participated in any other trial within 30 days prior to the last visit of that study and day 0 of this study.
  • •4. Patients with severe general health conditions (multiple trauma, acute life-threatening diseases, high risk for general anesthesia)
  • •5. Subject is dependent on the sponsor or investigators in a familiar or financial manner

Investigators

Similar Trials